Health Condition 1: E114- Type 2 diabetes mellitus with neurological complications
Conditions
Interventions
None listed
Sponsors
Dr Ayush Dhankhar
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients having cardinal symptoms of Madhumeha Upadrava like Daha, Harsha, Suptata and Shula will be selected. 2.Diagnosed case of Type 2 Diabetic Neuropathy will be included. 3.Mild to moderate Neuropathy patients having Toronto score between 6 to 11 will be included. 4.Both fresh and treated cases will be included in the study. 5.On-going oral hypoglycaemic agents will be continued during study. 6.No other neuropathy managing drugs are allowed during study period. 7.Patient who are willing to sign written consent will be included.
Exclusion criteria
Exclusion criteria: 1.IDDM (Type 1 DM) will be excluded from study. 2.Diabetic patients with chronic alcoholism will be excluded. 3.Pregnant and lactating women will be excluded. 4.Patient with any other serious condition which have negative impact on the nerves like Meningitis/encephalitis/Polio etc. will be excluded. 5.Patient having any other associated clinical condition like Dementia, Parkinson, Stroke which influence peripheral nerve function will be excluded. 6.Patient having ulceration/infection of feet. 7.Medical/Surgical condition limiting functional mobility. 8.Non ambulatory patients. 9.Patients who are not willing to participate / consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Effect of trial drug in classical symptoms of Diabetic Neuropathy and neuro-regeneration assessed by Toronto clinical neuropathy score and Vibration perception Threshold(VPT) Timepoint: 15day,30day, 60day | — |
Secondary
| Measure | Time frame |
|---|---|
| Safety of Trial drug & Adverse drug Reaction & Aggravation of the Symptoms of Diabetic NeuropathyTimepoint: 15day,30day,60day | — |
Countries
India
Contacts
Public ContactDr Ayush Dhankhar
Sidramappa Danigond Memorial Trusts Ayurvedic Medical College Post Graduation Centre
Outcome results
None listed